Close

Zoetis (ZTS): Clavamox Chewable antibiotic Study Success Underscores Positive Thesis - Cantor

August 15, 2017 7:28 AM EDT Send to a Friend
Cantor Fitzgerald analyst, Louise Chen, reiterated her Overweight rating on shares of Zoetis Inc. (NYSE: ZTS) after the company conducted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login